Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Your Profile Become a Member/Get Newsletter Log In Contact Us
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
The Schizophrenia Research Forum web site is sponsored by NARSAD, the Mental Health Research Association, and supported in part by a contract from the National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services
Online Discussions

Updated 15 October 2007

The Schizophrenia Research Forum holds online discussions periodically on selected topics. Working with one or more researchers who are experts in the topic, we arrange access to published papers or prepare background text as a basis for reader commentary. Currently, we hold two types of discussions:

Live Discussions are scheduled live chats on important recent trends, controversies, or publications. Each discussion is preceded by a background text and led by one or more experts in the topic being discussed. Topics are announced several weeks ahead and advance commentary is solicited. After the live chat, transcripts of discussions are edited and posted.

All Live Discussions will be held from 12 noon-1 p.m. EST unless noted otherwise. Time Zone Converter

Forum Discussions are sometimes topical discussions—as described above, but without the live chat. We will also hold regular Forum Discussions that are like "journal clubs," featuring a recently published paper from Schizophrenia Bulletin. The journal editors will provide a short introduction to the paper, and we invite readers to comment. Full-text access to the paper is available through SRF.

The views of online discussion participants do not necessarily reflect the opinions of the Schizophrenia Research Forum or its editors.


Upcoming Discussions

To be announced.


Ongoing Discussions

To be announced.


Previous Discussions

New Approaches to Cognition in Mental Illness
Led by Fred Sabb, Bob Bilder, and Deanna Barch.
Live discussion held 9 June 2008.

Disease Progression in Schizophrenia
Send in your comments now! The papers under discussion:
Lawrie SM, McIntosh AM, Hall J, Owens DG, Johnstone EC. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk.

Wood SJ, Pantelis C, Velakoulis D, Yücel M, Fornito A, McGorry PD. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk.

Gene Expression Profiling of Postmortem Human Brain
Led by Akira Sawa and Marquis Vawter.
Live discussion held 9 January 2008
View Transcript of Live Discussion

Truly Better Prognosis in the Developing World?
Send in your comments now! The paper under discussion:
Cohen A, Patel V, Thara R, Gureje O. Free Full Text Questioning an Axiom: Better Prognosis for Schizophrenia in the Developing World? Schizophr Bull. 2007 Sep 28; [Epub ahead of print]

Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Send in your comments now! The paper under discussion:
Gray JA, Roth BL. Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia. Schizophr Bull. 2007 Jul 7; [Epub ahead of print]

The New Epidemiology of Schizophrenia
Led by John McGrath.
Live Discussion held 11 April 2007.
View Transcript of Live Discussion

Antibodies to Toxoplasma gondii in Patients with Schizophrenia: A Meta-Analysis
Send in your comments now! The paper under discussion:
Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis.

The DISC1 Pathway in Major Mental Illness: Clinical, Genetic and Biological Evidence—Current Status and Future Prospects
Led by David Porteous.
Live discussion held 23 January 2007.
View Transcript of Live Discussion

Addressing Cardiovascular Risk Factors in Schizophrenia Patients
The paper under discussion:
Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, Lieberman JA. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006 Sep;86(1-3):15-22. Epub 2006 Aug 1.

Is Active Psychosis Neurotoxic?
The paper under discussion:
McGlashan TH. Is Active Psychosis Neurotoxic? Schizophr Bull. 2006; 32:609-613.

The Lack of Delay in the “Onset” of Antipsychotic Action: Implications from the Bench to the Bedside
Led by Ofer Agid and Shitij Kapur.
Live discussion held 12 September 2006.
View Transcript of Live Discussion

Is BDNF's Star Fading in the Schizophrenia Research Universe?
The paper under discussion:
Tochigi M, Otowa T, Suga M, Rogers M, Minato T, Yamasue H, Kasai K, Kato N, Sasaki T. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr Res. 2006 Jul 17; [Epub ahead of print]

The NIMH-MATRICS Consensus Statement on Negative Symptoms—Schizophrenia Bulletin
The paper under discussion:
Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS Consensus Statement on Negative Symptoms. Schizophr Bull. 2006 Feb 15; [Epub ahead of print]

New Findings in Psychosis: Breaking Down Diagnostic Barriers
Led by Nick Craddock and Mike Owen.
Live discussion held 15 May 2006.
View Transcript of Live Discussion

Identifying Phenotypes and Endophenotypes in Schizophrenia (Psychosis) Research
Led by Irv Gottesman and Mayada Akil.
Live discussion held 10 January 2006.
View Transcript of Live Discussion


Desperately

Antibodies
Collaborators

SWhat We Know About Schizophrenia

What We Know About Schizophrenia
We invite your comments and suggested edits to these facts about schizophrenia.

Compiled by Angus MacDonald, S. Charles Schulz, and the Minnesota Consensus Group.
Copyright © 2005- 2008 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright